Filter
Sort
Issue 6
Issue 6

Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for...

Expires: 05.30.2025
Issue 5
Issue 5

When is it appropriate to include an NNRTI (non-nucleoside reverse transcriptase inhibitor) like rilpivirine or doravirine in an ART regimen? What do...

Expires: 05.16.2025
Issue 4
Issue 4

Patients with HIV that cannot be treated with currently available therapies because of multiple resistance mutations. ART with cumbersome dosing sched...

Expires: 04.26.2025
Issue 3
Issue 3

Multiple sclerosis is a disease that affects people of all genders, races, ethnicities, and socioeconomic status. Why, then, are certain individuals n...

Expires: 04.11.2025
Issue 3
Issue 3

Results from recent studies of two first-in-class antiretrovirals, as well as preliminary results of broadly neutralizing antibody therapies, may expa...

Expires: 03.28.2025
Issue 2
Issue 2

In her Expert Commentary, Dr. Melanie Ward from West Virginia University’s Rockefeller Neuroscience Institute provided analysis of the newer dat...

Expires: 03.07.2025
Issue 1
Issue 1

What does the recent research say about the risk factors for developing MS? How significant is past Epstein-Barr virus/infectious mononucleosis infect...

Expires: 02.01.2025
Issue 2
Issue 2

Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their m...

Expires: 01.11.2025
Issue 1
Issue 1

Among the LGBTQ+ population, why is HIV virologic suppression lower in the transgender and gender-diverse (trans) populations? Why are trans women 66...

Expires: 01.09.2025
Issue 8
Issue 8

Individuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how ha...

Expires: 12.22.2024
Issue 7
Issue 7

Cystic fibrosis and weight gain. For most of their lives, individuals with CF have struggled to gain weight and achieve BMI norms. For most, despite t...

Expires: 12.22.2024
Saving Sight: Vision Protection & Blindness Prevention in Diabetes
  • Webinar
  • External
Saving Sight: Vision Protection & Blindness Prevention in Diabetes

Diabetic retinopathy is the leading cause of blindness in working-age adults, but timely treatment can reduce the risk of vision loss by 95%.

Expires: 11.03.2024
2022 Special Edition, Issue 2
2022 Special Edition, Issue 2

Hepatitis B. It may not be curable yet, but as our knowledge continues to grow, so does our ability to benefit our patients today as we prepare them f...

Expires: 10.19.2024
2022 Special Edition, Issue 1
2022 Special Edition, Issue 1

Hepatitis B. Unlike Hep C, it’s not curable — yet. But as the research continues and the knowledge base continues to grow, the cure gets c...

Expires: 10.19.2024
Issue 12
Issue 12

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV dr...

Expires: 10.10.2024
Issue 12
Issue 12

How aware are clinicians that MS should no longer be considered a “White people only” disease? What roles have race and ethnicity been sho...

Expires: 10.03.2024